- Home
- FLWS vs GOSS Comparison
FLWS vs GOSS Comparison
Compare FLWS & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLWS
- GOSS
- Stock Information
- Founded
- FLWS 1976
- GOSS 2015
- Country
- FLWS United States
- GOSS United States
- Employees
- FLWS N/A
- GOSS N/A
- Industry
- FLWS Other Specialty Stores
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- FLWS Consumer Discretionary
- GOSS Health Care
- Exchange
- FLWS Nasdaq
- GOSS Nasdaq
- Market Cap
- FLWS 347.1M
- GOSS 347.8M
- IPO Year
- FLWS 1999
- GOSS 2019
- Fundamental
- Price
- FLWS $5.60
- GOSS $2.47
- Analyst Decision
- FLWS Hold
- GOSS Strong Buy
- Analyst Count
- FLWS 1
- GOSS 4
- Target Price
- FLWS $7.50
- GOSS $8.50
- AVG Volume (30 Days)
- FLWS 349.6K
- GOSS 3.1M
- Earning Date
- FLWS 09-04-2025
- GOSS 08-05-2025
- Dividend Yield
- FLWS N/A
- GOSS N/A
- EPS Growth
- FLWS N/A
- GOSS N/A
- EPS
- FLWS N/A
- GOSS N/A
- Revenue
- FLWS $1,709,948,000.00
- GOSS $40,237,000.00
- Revenue This Year
- FLWS N/A
- GOSS N/A
- Revenue Next Year
- FLWS N/A
- GOSS $30.65
- P/E Ratio
- FLWS N/A
- GOSS N/A
- Revenue Growth
- FLWS N/A
- GOSS N/A
- 52 Week Low
- FLWS $3.86
- GOSS $0.66
- 52 Week High
- FLWS $9.24
- GOSS $2.65
- Technical
- Relative Strength Index (RSI)
- FLWS 50.17
- GOSS 68.08
- Support Level
- FLWS $5.37
- GOSS $2.38
- Resistance Level
- FLWS $5.58
- GOSS $2.65
- Average True Range (ATR)
- FLWS 0.22
- GOSS 0.15
- MACD
- FLWS 0.00
- GOSS 0.03
- Stochastic Oscillator
- FLWS 63.49
- GOSS 76.67
About FLWS 1-800-FLOWERS.COM Inc.
1-800-Flowers.com Inc is a provider of gifts designed to help customers express, connect, and celebrate. The company's e-commerce business platform features all brands, including 1-800-Flowers.com, 1-800-Baskets.com, Cheryl's Cookies, Harry and David, PersonalizationMall.com, Shari's Berries, FruitBouquets.com, Moose Munch, The Popcorn Factory, Wolferman's Bakery, Stock Yards, and Simply Chocolate. The company's business segments are; Consumer Floral and Gifts, BloomNet, and Gourmet Foods & Gift Baskets. The maximum revenue for the company is generated from its Gourmet Foods & Gift Baskets segment.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.